KYFORA BIO

Serial Number 97372045
Registration 7626969
700

Registration Progress

Application Filed
Apr 20, 2022
Under Examination
Nov 21, 2023
Approved for Publication
Sep 26, 2023
Published for Opposition
Sep 26, 2023
Registered
Dec 24, 2024

Trademark Image

KYFORA BIO

Basic Information

Serial Number
97372045
Registration Number
7626969
Filing Date
April 20, 2022
Registration Date
December 24, 2024
Published for Opposition
September 26, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 24, 2024
Registration
Registered
Classes
005 042

Rights Holder

KYFORA BIO, LLC

16
Address
767 Electronic Drive
Horsham, PA 19044

Ownership History

The Ott Group, Inc.

Original Applicant
03
Warrington, PA

The Ott Group, Inc.

Owner at Publication
03
Warrington, PA

KYFORA BIO, LLC

New Owner After Publication #1
16
Horsham, PA

KYFORA BIO, LLC

Original Registrant
16
Horsham, PA

Legal Representation

Attorney
David M. Tener, Esq.

USPTO Deadlines

Next Deadline
1822 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241224)
Due Date
December 24, 2030
Grace Period Ends
June 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Dec 24, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 24, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 3, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 3, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 2, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 21, 2024 IUAF S USE AMENDMENT FILED Loading...
Nov 21, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 18, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jul 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 18, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 21, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 18, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
May 22, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Jun 28, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 24, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 24, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 24, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 21, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 2, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 2, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 2, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 27, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 21, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 26, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 26, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 6, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 21, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 14, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 15, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 15, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Feb 14, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 14, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 14, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 23, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Chemical preparations for medical use for research and for genetic diagnostics, namely, for the discovery, development and delivery of cell and gene therapies for treating genetic diseases; Diagnostic agents for medical use for research and for genetic diagnostics; Reagents for medical use for research and for genetic diagnostics; Chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; Medicines for the treatment of genetic diseases
First Use Anywhere: 20240500
First Use in Commerce: 20240500
Class 042
Analyses in the field of molecular biology; Analysis of the chemical composition of liquids; Chemical analysis; Chemical and biochemical analyses; Chemical engineering services; Chemical laboratory services; Chemical research; Chemical technology research; Computer-aided scientific testing of DNA samples for diagnostic purposes; Scientific research in the nature of conducting clinical trials for others for pharmaceutical and genetic products; Consultancy in the field of pharmaceutical research; Consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemicals used in the field of genetics; Development of new products in the field of gene therapy; Development of pharmaceutical preparations and medicines; Development of pharmaceutical products; Testing and evaluation of chemicals; Genetic analyses for scientific research purposes; Industrial packaging design services; Inspection of pharmaceutical products; Laboratory research in the field of genetics; Laboratory research services concerning pharmaceutical products; Pharmaceutical product development services; Pharmaceutical research services; Provision of information concerning the results of clinical trials for pharmaceutical products; Quality evaluation of pharmaceutical products; Research and development for the pharmaceutical industry; Research and development of new products for third parties; Research in the field of pharmaceutical products; Scientific analyses and research in the field of transfection; Scientific development of transfection agents; Scientific research for medical purposes in the field of genetics and genetic engineering; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of medicines; Scientific testing services in the field of genetics; Services of a genetic research laboratory, namely, genetic testing for scientific research purposes and development of gene therapies for medical purposes; Software design and computer software design in the field of scientific research and genetic analyses; Structural and functional analysis of genomes; Testing of chemical products; Testing on pharmaceutical products
First Use Anywhere: 20240500
First Use in Commerce: 20240500

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"